NTV Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

NTV Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.43M	Buy	23,625 +820	+4%	+$47.8K	0.16%	127
2025 Q4	$1.23M	Sell	22,805 -3,250	-12%	-$156K	0.13%	132
2025 Q3	$1.18M	Sell	26,055 -4,189	-14%	-$196K	0.13%	131
2025 Q2	$1.4M	Sell	30,244 -1,300	-4%	-$63.8K	0.17%	115
2025 Q1	$1.92M	Sell	31,544 -1,000	-3%	-$58.3K	0.26%	85
2024 Q4	$1.84M	Sell	32,544 -149	-0.5%	-$8.32K	0.24%	87
2024 Q3	$1.69M	Sell	32,693 -774	-2%	-$36.3K	0.23%	90
2024 Q2	$1.39M	Sell	33,467 -239	-0.7%	-$10.7K	0.2%	97
2024 Q1	$1.83M	Buy	33,706 +2,884	+9%	+$147K	0.28%	79
2023 Q4	$1.58M	Sell	30,822 -1,502	-5%	-$78.8K	0.27%	80
2023 Q3	$1.88M	Sell	32,324 -1,300	-4%	-$79.7K	0.34%	69
2023 Q2	$2.15M	Hold	33,624	–	–	0.38%	67
2023 Q1	$2.33M	Hold	33,624	–	–	0.43%	60
2022 Q4	$2.42M	Buy	33,624 +300	+0.9%	+$22.6K	0.48%	57
2022 Q3	$2.37M	Sell	33,324 -500	-1%	-$36.3K	0.5%	57
2022 Q2	$2.6M	Buy	33,824 +733	+2%	+$55.8K	0.51%	56
2022 Q1	$2.42M	Buy	33,091 +1,799	+6%	+$121K	0.41%	70
2021 Q4	$1.95M	Buy	31,292 +700	+2%	+$41.1K	0.32%	80
2021 Q3	$1.81M	Buy	30,592 +500	+2%	+$32.9K	0.31%	85
2021 Q2	$2.01M	Sell	30,092 -350	-1%	-$22.8K	0.36%	78
2021 Q1	$1.92M	Buy	30,442 +717	+2%	+$44.6K	0.36%	76
2020 Q4	$1.84M	Sell	29,725 -600	-2%	-$36.9K	0.37%	72
2020 Q3	$1.83M	Sell	30,325 -100	-0.3%	-$6.02K	0.43%	65
2020 Q2	$1.79M	Buy	30,425 +1,700	+6%	+$102K	0.46%	62
2020 Q1	$1.6M	Sell	28,725 -342	-1%	-$20.9K	0.53%	56
2019 Q4	$1.87M	Buy	29,067 +700	+2%	+$40.1K	0.48%	60
2019 Q3	$1.44M	Sell	28,367 -1,200	-4%	-$56.4K	0.41%	70
2019 Q2	$1.34M	Sell	29,567 -1,550	-5%	-$72.2K	0.38%	73
2019 Q1	$1.49M	Buy	31,117 +300	+1%	+$14.9K	0.42%	69
2018 Q4	$1.6M	Sell	30,817 -1,950	-6%	-$105K	0.52%	58
2018 Q3	$2.03M	Hold	32,767	–	–	0.55%	60
2018 Q2	$1.81M	Sell	32,767 -2,300	-7%	-$124K	0.51%	65
2018 Q1	$2.22M	Sell	35,067 -400	-1%	-$25.7K	0.63%	53
2017 Q4	$2.17M	Sell	35,467 -200	-0.6%	-$12.5K	0.61%	55
2017 Q3	$2.27M	Sell	35,667 -1,150	-3%	-$67.1K	0.66%	52
2017 Q2	$2.05M	Buy	36,817 +800	+2%	+$43.5K	0.62%	55
2017 Q1	$1.96M	Buy	36,017 +500	+1%	+$27.4K	0.62%	56
2016 Q4	$2.08M	Hold	35,517	–	–	0.72%	46
2016 Q3	$1.92M	Buy	35,517 +7,700	+28%	+$495K	0.69%	52
2016 Q2	$2.04M	Sell	27,817 -250	-0.9%	-$17.7K	0.77%	44
2016 Q1	$1.79M	Hold	28,067	–	–	0.69%	46
2015 Q4	$1.93M	Sell	28,067 -7,000	-20%	-$463K	0.76%	38
2015 Q3	$2.08M	Sell	35,067 -200	-0.6%	-$12.7K	0.67%	39
2015 Q2	$2.35M	Sell	35,267 -450	-1%	-$29.7K	0.69%	42
2015 Q1	$2.3M	Sell	35,717 -250	-0.7%	-$15.7K	0.69%	43
2014 Q4	$2.12M	Sell	35,967 -1,200	-3%	-$67.7K	0.63%	46
2014 Q3	$1.9M	Hold	37,167	–	–	0.58%	57
2014 Q2	$1.8M	Sell	37,167 -350	-0.9%	-$17.2K	0.55%	58
2014 Q1	$1.95M	Hold	37,517	–	–	0.62%	52
2013 Q4	$1.99M	Hold	37,517	–	–	0.68%	44
2013 Q3	$1.74M	Sell	37,517 -7,550	-17%	-$331K	0.61%	53
2013 Q2	$2.01M	Buy	+45,067	New	+$1.96M	0.73%	41

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NTV Asset Management's BMY Position: Q1 2026 in Review

NTV Asset Management increased its Bristol-Myers Squibb (BMY) stake by 3.6% in Q1 2026, buying an estimated $47.8K and bringing the position to 23,625 shares worth $1.43M. The position accounts for 0.16% of the portfolio, ranked #127.

NTV Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.6M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

NTV Asset Management held 23,625 shares of Bristol-Myers Squibb worth $1.43M as of Q1 2026.
NTV Asset Management bought 820 Bristol-Myers Squibb shares in Q1 2026, an estimated $47.8K.
Bristol-Myers Squibb made up 0.16% of NTV Asset Management's portfolio in Q1 2026, its #127 holding.
NTV Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
NTV Asset Management's Bristol-Myers Squibb position peaked at $2.6M in Q2 2022.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on NTV Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.